Leadership Shake-Up: Hamid Ahmed Resigns from Religare Board Amidst Burman Family's Acquisition Moves
Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned as an independent director from Religare Enterprises due to family business commitments. The resignation follows the Burman family's bid for a 26% stake in Religare and subsequent allegations of insider trading against company leaders.

- Country:
- India
Hamid Ahmed, the CEO of Hamdard Laboratories India's Foods Division, has stepped down as an independent director of Religare Enterprises, effective February 4, 2025, citing increased responsibilities in his family's business.
This resignation surfaces amidst an open offer by the Burman family, well-known for their association with Dabur India, to acquire a 26% stake in Religare, resulting in regulatory complaints and allegations of insider trading by the company's chairperson.
The situation escalated with independent directors of Religare raising concerns about potential fraud and regulatory breaches which have been brought to the attention of various regulatory bodies, including SEBI, RBI, and the Insurance Regulatory and Development Authority.
(With inputs from agencies.)
ALSO READ
Adani Infra Seeks CCI Approval for PSP Projects Stake Acquisition
Tata Sons Eyes Greater Control of Tata Play with Additional Stake Acquisition
Dabur India Posts Strong Q3 Financial Performance
Dabur India's Resilient Growth Amidst High Food Inflation
Ex-Ipsen Executive Lands Two-Month Sentence for Insider Trading